A Biomimetic Mn-Doped Polydopamine Nanoplatform for MRI-Enabled Synergistic Therapy to Enhance Lenvatinib Efficacy in Liver Cancer
not only triggered chemodynamic therapy through Fenton-like reactions but also enabled magnetic resonance imaging (MRI). In addition, PML@CM nanoparticles exhibited an efficient photothermal conversion performance for tumor photothermal therapy. In conclusion, this nanoplatform provides a promising therapeutic strategy for MRI-enabled synergistic therapy against liver cancer.
Authors
- Hu Hongtao
- Yana Ma
- Ruican Nie
- Dongqiu Shan
- Weijia Zhu
- Ho-Young Song
- Wen Luo
- Shijun Xu
- Yue Wu
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- ACS Applied Materials & Interfaces
- Published
- 2026-04-20
- DOI
- https://doi.org/10.1021/acsami.6c00228
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Henan Province
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Foundation of Henan Province
- Henan Provincial Science and Technology Research Project